Shanghai Xuerong Bio-Technology

What Shanghai Xuerong Bio-Technology does

Shanghai Xuerong Bio-Technology (上海雪榕生物科技股份有限公司) is China's largest factory-farmed edible fungus producer, founded in 1995 and listed on the Shenzhen Stock Exchange ChiNext (stock code 300511) on May 4, 2016. The company operates a '17+1' production system comprising 17 domestic factories plus one in Bangkok, Thailand, with daily production capacity of 1,170 tons as of end-2019, ranking first nationally. Core products span five fresh mushroom varieties — enoki (金针菇), shimeji (真姬菇), shiitake (香菇), king oyster (杏鲍菇), and the rarer Sparassis crispa (绣球菌) — supplemented by processed lines including ecological fresh mushrooms, plateau dried mushrooms, and mushroom snacks. The company holds 67 patents and 5 certified proprietary strains, with strain-level R&D recognized by the Ministry of Agriculture and Rural Affairs as a national crop seed industry key enterprise for edible fungi.

The business model is predominantly B2B sales-led through major supermarket chains (KA渠道) with packaged small-format products, complemented by B2C e-commerce (Tmall flagship store, WeChat mini-program, JD, Douyin livestreaming via the 'Mushroom Grandpa' persona) and food service supply to hotels and restaurants. Pricing is wholesale B2B plus retail B2C; specific price points are not publicly disclosed. The company has expanded into adjacent verticals: plant-based meat snacks via a July 2020 joint venture (Zhiba

Name

Shanghai Xuerong Bio-Technology

Legal name

上海雪榕生物科技股份有限公司

Website

https://xuerong.com

Company type

Public

Founded year

1995

Operating status

Operating

Headcount range

1–10 employees

Short description

Shanghai Xuerong Bio-Technology is China's largest factory-farmed edible fungus producer, operating 17 domestic factories plus one in Bangkok with 1,170 tons/day capacity, producing fresh enoki, shimeji, shiitake, and king oyster mushrooms for supermarket chains, food service, and e-commerce consumers nationwide.

Ownership category

akta.pro rank

Product category

Edible Mushroom Production

NAICS

Mushroom Production (111411), Food Manufacturing (311)

SIC

Agricultural Production-Crops (100), Food And Kindred Products (2000)

akta.pro primary industry

Mushroom & Fungi Production (Indoor/Protected) (AFAGAHAK)

akta.pro secondary industry

Seaweed & Dried Vegetable Snacks Manufacturing (AFAKAIAI)

Keywords

• Factory-farmed mushrooms
• Edible fungi production
• Mushroom strain breeding
• Fresh produce manufacturing
• Mushroom snack products

Headquarters

HQ city

Shanghai

HQ country

China

HQ region

Asia

Offices11 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Fresh Edible Mushroom Sales: Primary revenue from factory-farmed fresh edible mushrooms including金针菇 (enoki), 真姬菇 (shimeji), 香菇 (shiitake), and 杏鲍菇 (king oyster) sold to retail supermarkets and food service channels.
2. Healthcare/Pharmaceutical Products: 雪榕生物医药 subsidiary developing绣球菌 functional foods and pharmaceutical products with Japanese partners, targeting anticancer and immune health markets.
3. Plant-Based Meat/Snack Products: Joint venture with a1零食研究所 for plant-based meat snacks using mushroom protein; joint venture植白生物 (40% stake) targeting health snack market.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Core offering

Shanghai Xuerong Bio-Technology is China's largest factory-farmed edible mushroom producer, operating 17 domestic production bases plus one factory in Bangkok, Thailand (a '17+1' global system). The company industrially cultivates and sells fresh edible mushrooms — primarily enoki (金针菇), shimeji (真姬菇), shiitake (香菇), king oyster (杏鲍菇), and Sparassis crispa (绣球菌) — at a national #1 daily capacity of 1,170 tons. It also markets processed product lines including ecological fresh mushrooms (生态鲜菇), plateau dried mushrooms (高原干菇), and mushroom snacks (休闲零食), with extension into mushroom-derived biomedical/pharmaceutical products and plant-based meat snacks via joint ventures.

Product overview

上海雪榕生物科技股份有限公司 (Shanghai Xuerong Bio-Technology) operates as a factory-farmed edible mushroom production and distribution company. The product portfolio centers on five core fresh mushroom varieties — 金针菇 (enoki), 真姬菇 (shimeji), 香菇 (shiitake), 杏鲍菇 (king oyster), and 绣球菌 (cauliflower mushroom/Sparassis crispa) — supplemented by downstream processed products including 生态鲜菇 (ecological fresh mushrooms), 高原干菇 (plateau dried mushrooms), and 休闲零食 (mushroom snacks). The company has diversified into adjacent verticals including 雪榕生物医药 (biomedical/pharmaceutical applications of mushroom extracts) and plant-based meat snacks through a joint venture called 植白生物. All products carry the '航天品质' (aerospace quality) positioning, reflecting the company's status as a strategic partner of China's aerospace program. The company maintains 9 domestic production bases plus a Thailand factory (17+1 global production system) and leverages 67 patents and 5 recognized proprietary mushroom strains for seed-level differentiation.

Differentiator

Problem solved

Functional benefit

Brands

• 雪榕生物医药: Biomedical subsidiary focused on medicinal applications of edible fungi, particularly 绣球菌 (Sparassis crispa) research and development for pharmaceutical products
• 植白生物

Products and services

• Fresh Enoki Mushrooms (金针菇) Factory-farmed fresh enoki mushrooms, Xuerong's flagship variety, sold to supermarket chains (KA渠道), food service operators, and packaged retail consumers; the company's largest-volume mushroom product and a core revenue driver.
• Fresh Shimeji Mushrooms (真姬菇) Factory-farmed fresh shimeji mushrooms, one of the main varieties in the company's fresh mushroom portfolio, sold through the same B2B supermarket and food service channels.
• Fresh Shiitake Mushrooms (香菇) Factory-farmed fresh shiitake mushrooms sold to supermarket chains and food service channels, with daily capacity of 130 tons at the 2016 IPO and contributing to the company's #1 ranking in China's edible fungus category.
• Fresh King Oyster Mushrooms (杏鲍菇) Factory-farmed fresh king oyster mushrooms produced at the Gansu Lintao production base, designed for 55.2 tons/day capacity and positioned as one of the largest king oyster facilities in Northwest China.
• Fresh Sparassis crispa / Cauliflower Mushroom (绣球菌) Factory-farmed Sparassis crispa (绣球菌), a rare and precious edible fungus with significant nutritional and healthcare value, marketed for fresh consumption and as the foundation of mushroom-derived functional food and pharmaceutical products through the Xuerong Biomedical subsidiary.
• Ecological Fresh Mushrooms (生态鲜菇) Packaged fresh edible mushroom product line sold under the 'ecological mushroom' brand positioning, targeting health-conscious retail consumers via supermarket chains and the company's e-commerce stores.
• Plateau Dried Mushrooms (高原干菇) Packaged dried mushroom products derived from plateau regions, sold through retail and e-commerce channels as part of the company's processed product portfolio.
• Mushroom Snacks (休闲零食) Mushroom-based snack products including mushroom jerky and related snack items, sold through e-commerce channels (Tmall, WeChat store, livestreaming via 菇爷/Mushroom Grandpa) and featured as in-flight refreshments on China Southern Airlines.
• Edible Mushroom Seed/Strain Varieties (食用菌菌种) Proprietary mushroom strain/seed varieties developed and owned by the company (5 recognized certified strains and 67 patents covering strains, processes, and cultivation formulas), supporting the company's own production and forming the basis of its selection as a National Crop Seed Industry陣型 Enterprise for edible fungi.
• Xuerong Biomedical Mushroom-Derived Pharmaceutical and Functional Food Products (雪榕生物医药) Functional foods and pharmaceutical candidates derived from Sparassis crispa (绣球菌) extracts, including MH-3β (1-3) glucan compounds with anticancer, immune-activation, blood sugar-lowering, and anti-hypertensive properties; produced by the Xuerong Biomedical subsidiary in collaboration with the Chinese Academy of Sciences Shanghai Institute of Materia Medica and Japanese enterprise partners.
• Zhibai Bio Plant-Based Mushroom Protein Snacks (植白生物) Plant-based meat snack products using edible mushroom protein as a base ingredient, developed and sold through the Zhibai Bio (植白生物) joint venture with a1零食研究所; targets the health snack and plant-based protein consumer markets via a1's 500,000+ retail channel access.

Quantifiable outcome

• National daily production capacity ranking #1
• +1 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Four partnerships are on record, tiered core.

• 中国科学院上海药物研究所coreStrategic or Co-development Partner · 28 February 2022Research collaboration on medicinal value of 绣球菌 (Sparassis crispa), focusing on anticancer and immune activation properties; led to establishment of Xuerong Biomedical subsidiary.
• a1零食研究所 (a1 Snack Research Institute)coreStrategic or Co-development Partner · 14 July 2020Joint venture established in Xiamen, July 2020, focused on plant-based meat snacks using mushroom protein. Xuerong provides mushroom protein raw materials and R&D capabilities; a1 provides product development and 500,000+ retail channel access.
• 未食达 (Weishida)coreStrategic or Co-development Partner · 14 July 2020RMB 14 million investment for 10% equity stake; joint R&D of mushroom protein-based plant meat products. Target to develop next-generation plant-based meat using edible mushroom protein.
• Japanese Enterprise Partners (雪榕生物医药)coreStrategic or Co-development PartnerJapanese partner collaboration for 绣球菌 functional food production and gradual expansion into pharmaceutical field; leveraging Japanese biotechnology expertise.

Scale indicators7 records

Recent moves10 records

Expansion highlights6 records

Direct peers

• Highline Mushrooms: Canadian grower and marketer of fresh mushrooms including enoki, shiitake and specialty varieties, distributing to major North American retailers; closely comparable in product mix and supermarket channel focus.
• Monterey Mushrooms: One of the largest fresh mushroom producers in North America, growing and distributing multiple varieties to retail and foodservice; the closest direct analogue to Xuerong's factory-farmed fresh mushroom model.

Broad incumbents

• Bonduelle: Global canned, frozen and fresh vegetable producer with a long history of vegetable processing and supermarket distribution; overlaps with Xuerong in processed/preserved mushroom and vegetable products.
• Costa Group Holdings: Australian large-scale horticultural producer with mushroom operations and protected-crop farming; comparable in industrial fresh produce farming and supermarket supply.
• Olam Group: Global food and agri-business with extensive edible nuts, spices and specialty crop sourcing/processing operations; comparable as a large-scale agricultural producer with downstream food processing.
• Greenyard: European fresh and prepared vegetable/fruit producer with significant fresh-produce scale and processing capabilities; comparable as a large-scale fresh vegetable/mushroom supplier operating across multiple categories.

Emerging players

• Beyond Meat: Plant-based meat pioneer; relevant to Xuerong's 植白生物 JV pushing mushroom-protein plant-based snacks into the same end-markets, though different primary protein source.

Regional players

• Yuan Longping High-Tech Agriculture: Major Chinese listed seed and agricultural biotechnology company with seed industry leadership; comparable as a domestic Chinese agricultural leader with government-backed seed enterprise status.
• Starzen Co., Ltd. Japanese food company with mushroom product lines and ties to Japanese biotech partners; relevant given Xuerong's Japanese collaborations in Sparassis crispa functional foods.
• Beijing Dabeinong Technology Group (DBN): Chinese listed agricultural technology company active in seeds, crop protection and biotech; comparable as a domestic Chinese agricultural leader with similar R&D-driven differentiation and government ties.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/shanghai-xuerong-biotechnology-co-ltd-

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Shanghai Xuerong Bio-Technology